Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

GlaxoSmithKline Buys Back 1.3 Million Shares

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/04/2012 | 06:28pm CET

GlaxoSmithKline PLC (>> GlaxoSmithKline plc) said Friday it has purchased 1,300,000 ordinary shares to be held in treasury.

MAIN FACTS:

-Highest price paid: 1455 pence per share.

-Lowest price paid: 1425 pence per share.

-Shares at 1610 GMT down 1%, at 1427 pence, valuing the company at GBP72 billion.

-By Mark Shapland, Dow Jones Newswires; +44 207 8429358; mark.shapland@dowjones.com

Stocks mentioned in the article : GlaxoSmithKline plc, GlaxoSmithKline plc
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on GLAXOSMITHKLINE PLC
12/07 GLAXOSMITHKLINE : *rpt/ubs cuts glaxosmithkline price target to 1600 pence - 'ne..
12/06 GLAXOSMITHKLINE : *ubs cuts glaxosmithkline price target to 1600 pence - 'neutra..
12/06 ADAPTIMMUNE THERAPEUTICS : Announces Initiation of Myxoid/Round Cell Liposarcoma..
12/05 GLAXOSMITHKLINE : Dominique Limet to step down as CEO of ViiV Healthcare; Debora..
12/05 Astex Joins the Dementia Discovery Fund as a Strategic Investor
12/05 INNOVIVA : Relvar Ellipta 100/25 mcg gains approval in Japan for use in patients..
12/05 GLAXOSMITHKLINE : Dominique Limet to step down as CEO of ViiV Healthcare; Debora..
12/05 GlaxoSmithKline Says Limet To Step Down As CEO Of ViiV Venture
12/02 INNOVIVA : GSK files EU regulatory submission for once-daily closed triple combi..
12/02 GLAXOSMITHKLINE : NICE recommends first-of-its kind asthma treatment mepolizumab
More news
Sector news : Pharmaceuticals - NEC
12/07 MYLAN : EpiPen maker Mylan to restructure, cut workforce
12/07DJABBOTT LABORATORIES : Seeks to Terminate Alere Deal -- Update
12/07DJPFIZER : Fined $107 Million for Overcharging U.K. for Epilepsy Drug
12/07DJABBOTT LABORATORIES : Seeks to Terminate Alere Deal
12/07DJMARKET SNAPSHOT : Dow, S&P 500 Set Intraday Records, But Health-care Slumps On T..
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
12/05 Spark Strengthens Case For Hemophilia Gene Therapy
12/05 GLAXOSMITHKLINE : Robust Pipeline Supports Its 5.5% Dividend Yield
12/02 ALZHEIMER'S DISEASE : Does THC Hold The Key To A Cure?
12/02 5%+ DIVIDEND YIELD PORTFOLIO : Trump And The No Good, Very Bad Month (Nov 2016 R..
12/02 Glaxo files marketing application in Europe for inhaled triple combo COPD the..
Advertisement
Financials ( GBP)
Sales 2016 27 399 M
EBIT 2016 7 209 M
Net income 2016 2 313 M
Debt 2016 13 844 M
Yield 2016 5,54%
P/E ratio 2016 31,08
P/E ratio 2017 17,87
EV / Sales 2016 3,11x
EV / Sales 2017 2,88x
Capitalization 71 315 M
More Financials
Chart GLAXOSMITHKLINE PLC
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Full-screen chart
Technical analysis trends GLAXOSMITHKLINE PLC
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 17,8  GBP
Spread / Average Target 22%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Andrew Philip Witty Chief Executive Officer & Executive Director
Philip Roy Hampton Non-Executive Chairman
Simon Dingemans Chief Financial Officer & Executive Director
Birgitte Volck Head-Research & Development
Moncef Slaoui Executive Director & Chairman-Global Vaccines
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
GLAXOSMITHKLINE PLC6.52%90 193
JOHNSON & JOHNSON8.16%302 251
ROCHE HOLDING LTD.-19.14%189 614
PFIZER INC.-2.23%189 272
NOVARTIS AG-20.05%178 826
MERCK & CO., INC.13.71%165 594
More Results